"Site-restricted conjugation of native mAbs offers the best of two worlds"Read more
Strategy & Vision
We aim to position our proprietary Lx® linker at the frontline of the next generation ADC technology by offering semi-final linker-payload products and by partnering for the development of customized ADCs apart from LinXis’ own ADC development pipeline.
It is our vision to leverage our Lx® know-how to bring ADCs from concept to product registration and to the patient in order to become a pioneering leader in the development of effective ADCs.
To this end we endeavor to create alliances with (bio)-pharmaceutical leaders and contract manufacturing organizations (CMOs) to allow them to obtain their program deliverables on time and within budget. We develop partnerships with a dedicated strategy aimed at each of these target groups.